Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
about
Lung microbiology and exacerbations in COPDBacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospectsPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseVirus-induced exacerbations in asthma and COPDPathophysiology of viral-induced exacerbations of COPDViral Etiology of Chronic Obstructive Pulmonary Disease Exacerbations during the A/H1N1pdm09 Pandemic and Postpandemic PeriodA mouse model of lethal synergism between influenza virus and Haemophilus influenzae.Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.Cytokine inhibition in the treatment of COPD.Human β-defensin-2 production upon viral and bacterial co-infection is attenuated in COPD.Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPDCigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotypeThe role of the microbiome in exacerbations of chronic lung diseases.Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzaeMicrobiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins.Characterisation of winter respiratory viral infections in patients with asthma and COPD in Qatar.The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injuryExperimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.Effect of gene environment interactions on lung function and cardiovascular disease in COPD.Role of interleukin-1 and MyD88-dependent signaling in rhinovirus infection.Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study.Severe hypoalbuminemia is a strong independent risk factor for acute respiratory failure in COPD: a nationwide cohort study.The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implicationsIFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment TestBronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.The role of bronchodilator treatment in the prevention of exacerbations of COPD.Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection.Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Factors associated with change in exacerbation frequency in COPDVitamin D deficiency and the lung: disease initiator or disease modifier?Airways inflammation and treatment during acute exacerbations of COPD.Recognizing the importance of respiratory syncytial virus in chronic obstructive pulmonary disease.Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation.Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease.
P2860
Q22305860-4CA59BA2-8AAC-4642-A41E-FCA1AF36CA71Q26752882-2C10A554-142B-4987-A82B-4A343DE739B2Q26778685-8021C140-F4E0-46E9-89F0-264BAD00BDB5Q27000043-23961726-C682-4F9C-B793-BF31C697F49DQ27008731-E4D08E12-A847-4D7E-9DD1-9A9BB750F767Q28389402-9D16304E-D255-4C05-9629-F0EC09A72CA6Q30375530-4736D288-4962-43D0-9C45-4FA4B3584B1AQ30383989-7E4129B3-4F92-44DF-AC62-05CCDB4F2657Q33378956-2CBED0B6-2EAA-4FF5-84B2-83A13A7EB3E1Q33568552-EB37F226-25FA-4D25-BD9D-F01D893E3953Q33657752-02A62532-5144-446C-90AA-9776ED56E1ECQ33776839-79D26F93-2C80-4C0D-97AD-43E2CC943B8AQ33863436-4AD628FD-3B56-469F-BA84-2B825F4E2188Q34199591-343D847C-CF3D-4E98-9B3C-0602C3F1BD97Q34234995-602E80F5-F07B-41BD-A205-72EA5B9914C4Q34315062-661A9E35-A345-4174-8D07-38827060CFB0Q34386841-2A9773F9-99FD-4D19-938A-5131C44B7913Q34390389-7E66F78E-2D99-4CB3-8D70-0D74A15F706DQ34595699-099BD043-069A-4D0B-A702-75BAB1210E59Q34646468-9DE47C80-DACE-4144-9000-D18CE5FBD8FDQ34834259-B71C2B28-6D10-4F47-9C7F-DDB37F7BFC23Q34840845-B6FC4981-EF95-4DF1-A73B-6C99840E43A1Q35131487-C5C97095-F2A0-4FEE-BE85-39B92E3926B2Q35140251-D7BD8DE2-4C94-49D5-A915-C95087A524E3Q35544707-6F501B96-E5CF-48DD-BF55-2650AE9B7A94Q35766297-EFC496BF-18DA-4E20-B5CF-3B12C627F977Q35987288-935BF950-C664-42ED-B4A4-39B27CEBE511Q36110505-AE1FF215-D1AE-44EB-A0D1-F8DF3F346BAEQ36208417-2F5917F2-BD80-4954-8812-968288CCD3CBQ36321964-ECB5241D-FCDA-46BB-8A42-FB15B111081FQ36438669-DDB5200F-5444-4E5B-8628-61C5A5C71081Q36946923-26B7E851-D627-468C-8231-03F5CFE7432EQ36965646-963DE2DC-2A8B-4E06-801C-85A5FBF7969BQ37029615-235ED7BA-09D5-47F0-95C5-51473F747BADQ37071132-BC594319-FFBA-45AF-8374-2F24ADE1EFECQ37177373-64CEA9CD-C05A-4CE5-91F0-0FF6EF17824CQ37237665-14F0EF94-E30F-459C-8A22-9F50823146DEQ37396913-CD51DE09-7E08-4E9D-9630-BA2C29165CA8Q37428607-8A80A719-9EAA-4C7D-980E-6CDF8CE05A88Q37668864-4BBC7CE8-B2F7-4A20-BD11-AA05127A49A2
P2860
Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Effect of interactions between ...... tion in exacerbations of COPD.
@en
Effect of interactions between ...... tion in exacerbations of COPD.
@nl
type
label
Effect of interactions between ...... tion in exacerbations of COPD.
@en
Effect of interactions between ...... tion in exacerbations of COPD.
@nl
prefLabel
Effect of interactions between ...... tion in exacerbations of COPD.
@en
Effect of interactions between ...... tion in exacerbations of COPD.
@nl
P2093
P356
P1433
P1476
Effect of interactions between ...... tion in exacerbations of COPD.
@en
P2093
Gavin C Donaldson
Jadwiga A Wedzicha
John R Hurst
Mark Wilks
Tom M A Wilkinson
Wayomi R Perera
P304
P356
10.1378/CHEST.129.2.317
P407
P577
2006-02-01T00:00:00Z